Private corrections company GEO Group (NYSE:GEO) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 13.1% year on year to $682.3 million. On the other hand, next quarter’s revenue guidance of $663.5 million was less impressive, coming in 4.7% below analysts’ estimates. Its GAAP profit of $1.24 per share was 58.8% above analysts’ consensus estimates.
Is now the time to buy GEO? Find out in our full research report (it’s free for active Edge members).
Revenue: $682.3 million vs analyst estimates of $665.7 million (13.1% year-on-year growth, 2.5% beat)
EPS (GAAP): $1.24 vs analyst estimates of $0.78 (58.8% beat)
Adjusted EBITDA: $120.1 million vs analyst estimates of $120.1 million (17.6% margin, in line)
Revenue Guidance for Q4 CY2025 is $663.5 million at the midpoint, below analyst estimates of $696.2 million
EPS (GAAP) guidance for Q4 CY2025 is $0.25 at the midpoint, missing analyst estimates by 17.4%
EBITDA guidance for the full year is $460 million at the midpoint, below analyst estimates of $471.8 million
Operating Margin: 6%, down from 13.7% in the same quarter last year
Market Capitalization: $2.1 billion
GEO Group’s third quarter was marked by substantial revenue growth, but the market reacted negatively as margin pressures and near-term headwinds overshadowed the top-line beat. Management attributed the sales gains to new and expanded contracts with U.S. Immigration and Customs Enforcement (ICE) and the U.S. Marshals, which drove facility occupancy and transportation services. CEO George Zoley highlighted that “these facility activations have increased our total ICE capacity to over 26,000 beds, and our current census is over 22,000, the highest ICE population we’ve ever had.” However, higher staffing costs and the expense of ramping up new contracts weighed on overall profitability.
Looking ahead, GEO Group’s guidance reflects uncertainty, with management citing delays in new contract awards and the impact of government staffing and shutdowns as key risks. CFO Mark Suchinski noted that reduced contract pricing for the ISAP 5 electronic monitoring program and additional start-up costs at reactivated facilities will dampen margins in the upcoming quarter. Zoley emphasized, “The pace of new detention contracts has been slower than anticipated,” pointing to bureaucratic hurdles and ICE staffing shortages. The company is focused on normalizing operations and integrating recent contract wins to support future revenue growth, but expects operating challenges to persist in the near term.
Management attributed Q3 performance to record contract wins, ICE facility activations, and secure transportation growth, while noting that ramp-up costs and shifting contract economics pressured margins.
ICE facility activations: GEO activated five major ICE detention facilities in 2025, raising ICE bed capacity and census to record levels. These contracts, including Delaney Hall and the North Lake Facility, significantly increased occupancy and are expected to contribute more as they normalize next year.
ISAP 5 contract awarded: The company secured a new two-year contract for the Intensive Supervision Appearance Program (ISAP 5), a key electronic monitoring initiative for immigrants, which includes both increased participant counts and lower unit pricing. Management noted that this contract required margin concessions but positions GEO for future growth in electronic monitoring services.
Secure transportation expansion: GEO expanded its secure ground and air transportation services for ICE and the U.S. Marshals, signing a new five-year contract covering 26 federal judicial districts. This segment is expected to add roughly $60 million in incremental annualized revenue.
Adelanto facility reactivation: The reopening of the Adelanto ICE Facility in California created additional start-up costs, including hiring and overtime expenses, which pressured margins this quarter but are expected to normalize in 2026 as operations stabilize.
Share buyback and asset sales: GEO completed the sale of the Lawton, Oklahoma facility, using proceeds to reduce debt and fund share repurchases. The board expanded the stock buyback authorization to $500 million, with management emphasizing opportunistic capital allocation amid perceived undervaluation.
Guidance for the next quarter and year is shaped by contract ramp-ups, cost management measures, and uncertainty surrounding government actions and staffing levels.
ISAP 5 margin and mix shift: The new ISAP 5 contract features lower pricing but anticipates a shift toward higher-intensity monitoring devices (such as ankle monitors), which carry higher costs and service intensity. Management expects this mix to eventually benefit margins as case management services expand, though short-term profitability is pressured by the transition.
Contract ramp-up and normalization: Recent contract wins, particularly the newly activated ICE facilities, require significant start-up investment in staffing and operations. The company expects these costs to normalize in 2026, supporting a step-up in both revenues and profitability if facility utilization remains high.
Government and staffing delays: Progress toward scaling up ICE detention capacity is slower than anticipated, due to bureaucratic reviews, government shutdowns, and ICE’s need to double its staff. Management views these delays as temporary, but notes that timing and volume of new contract awards remain outside GEO’s control.
In the quarters ahead, the StockStory team will be watching (1) the ramp-up and normalization of new ICE facility contracts and whether utilization rates remain high; (2) the pace and mix of participant growth in the ISAP 5 program, including the adoption of higher-intensity monitoring devices; and (3) progress in managing staffing costs and operational efficiencies as facility activations stabilize. Developments in government contract timing and ICE funding will also be important indicators for GEO’s future outlook.
GEO Group currently trades at $15.13, down from $16.82 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free for active Edge members).
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
